Table 2.
Association between quantitative patients’ characteristics and cfPWV in RA patients
| Rho | Significance (p) | |
|---|---|---|
| Age | 0.544 | 0.001* (−) |
| Disease duration | 0.021 | 0.903 (0.913)‡ |
| CRP | −0.027 | 0.876 (0.053)‡ |
| ESR | −0.031 | 0.859 (0.170)‡ |
| RF | 0.369 | 0.025*(0.462)‡ |
| Anti-CCP | 0.142 | 0.401 (0.345)‡ |
| TJC | 0.330 | 0.065 (0.034*)‡ |
| SJC | −0.065 | 0.713 (0.744)‡ |
| VAS | 0.117 | 0.509 (0.763)‡ |
| DAS28 (ESR) | 0.191 | 0.331 (0.658)‡ |
| DAS28 (CRP) | 0.213 | 0.266 (0.499)‡ |
Spearman rho was used
RA rheumatoid arthritis, CRP C-reactive protein, ESR erythrocyte sedimentation rate, RF rheumatoid factor; Anti-CCP cyclic citrullinated peptide antibodies, TJC tender joints count, SJC swollen joints count, VAS visual analogue scale, DAS28 disease activity score 28
* p < 0.05
‡in parentheses p values adjusted for age and obesity by multiple regression